NYSE - Nasdaq Real Time Price USD
Annovis Bio, Inc. (ANVS)
At close: November 4 at 4:00 PM EST
After hours: November 4 at 6:28 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
40,878.04
45,035.01
25,511.28
14,500.47
5,482.77
Operating Income
-40,878.04
-45,035.01
-25,511.28
-14,500.47
-5,482.77
Net Non Operating Interest Income Expense
-1,063.13
667.90
182.71
13.34
47.23
Other Income Expense
--
-11,837.20
--
--
-26.50
Pretax Income
-43,017.37
-56,204.31
-25,328.57
-14,487.13
-5,462.05
Net Income Common Stockholders
-43,017.37
-56,204.31
-25,328.57
-14,487.13
-5,462.05
Diluted NI Available to Com Stockholders
-43,017.37
-56,204.31
-25,328.57
-14,487.13
-5,462.05
Basic EPS
-4.54
-6.23
-3.10
-1.90
-0.87
Diluted EPS
-4.54
-6.23
-3.10
-1.90
-0.87
Basic Average Shares
10,218.72
9,023.14
8,162.33
7,626.28
6,308.96
Diluted Average Shares
10,268.65
9,023.14
8,162.33
7,626.28
6,308.96
Total Operating Income as Reported
-40,878.04
-45,035.01
-25,511.28
-14,537.22
-6,640.22
Total Expenses
40,878.04
45,035.01
25,511.28
14,500.47
5,482.77
Net Income from Continuing & Discontinued Operation
-43,017.37
-56,204.31
-25,328.57
-14,487.13
-5,462.05
Normalized Income
-41,941.17
-44,367.11
-25,328.57
-14,487.13
-5,435.55
Interest Income
282.93
667.90
182.71
13.34
47.23
Net Interest Income
-1,063.13
667.90
182.71
13.34
47.23
EBIT
-40,878.04
-45,035.01
-25,511.28
-14,500.47
-5,482.77
EBITDA
-40,878.04
-45,035.01
-25,511.28
-14,500.47
-5,482.77
Net Income from Continuing Operation Net Minority Interest
-43,017.37
-56,204.31
-25,328.57
-14,487.13
-5,462.05
Total Unusual Items Excluding Goodwill
-1,076.20
-11,837.20
--
--
-26.50
Total Unusual Items
-1,076.20
-11,837.20
--
--
-26.50
Normalized EBITDA
-39,801.84
-33,197.81
-25,511.28
-14,500.47
-5,456.27
12/31/2020 - 1/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVXL Anavex Life Sciences Corp.
7.30
+6.80%
SAVA Cassava Sciences, Inc.
25.84
-1.41%
INMB INmune Bio, Inc.
6.25
+3.48%
COYA Coya Therapeutics, Inc.
6.85
-2.70%
ALT Altimmune, Inc.
6.79
+0.74%
TIL Instil Bio, Inc.
27.63
-4.00%
CADL Candel Therapeutics, Inc.
5.19
-1.70%
IKT Inhibikase Therapeutics, Inc.
2.6100
-1.14%
AXSM Axsome Therapeutics, Inc.
87.25
-1.79%
IOVA Iovance Biotherapeutics, Inc.
11.44
+2.23%